We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Urine Test Allows for Rapid Preeclampsia Diagnosis

By LabMedica International staff writers
Posted on 27 Mar 2019
Print article
Image: The CR Dot (CRD) Paper Test: each kit had two label papers incorporated, and a visual colorimetric scale marked as strongly positive (SP), weak positive (WP) and negative (NEG). The kit contained a syringe prefilled with Congo Red dye (Photo courtesy of The Ohio State University Wexner Medical Center).
Image: The CR Dot (CRD) Paper Test: each kit had two label papers incorporated, and a visual colorimetric scale marked as strongly positive (SP), weak positive (WP) and negative (NEG). The kit contained a syringe prefilled with Congo Red dye (Photo courtesy of The Ohio State University Wexner Medical Center).
Hypertensive disorders affect 15% of pregnancies and account for one quarter of the antenatal admissions. Preeclampsia (PE) is a multisystem disorder specific to human pregnancy, and its incidence varies from 5% to 60% of gestations, depending on maternal co-morbidities.

PE has a large spectrum of medical signs and symptoms resulting in a range of clinical phenotypes and outcomes, making a diagnosis on available clinical and laboratory parameters challenging. Hypertension and proteinuria are non-specific, and thus major challenges arise when differential diagnosis includes chronic hypertension, endocrine, and kidney diseases.

Scientists at The Ohio State University College of Medicine (Columbus, OH, USA) recruited 346 consecutive pregnant patients from the labor and delivery (L&D) triage unit at Wexner Medical Center (Columbus, OH, USA) and followed prospectively until delivery from July 2014 to July 2015. Eligible, consenting women were approached for enrollment by certified research nurses immediately after their presentation to the triage area before initiation of the clinical work-up for PE. The team designed, developed and validated a simple bedside, paper-based urine test kit, which they named the CR Dot (CRD) Paper Test.

Of the approached women, 353 (98%) agreed to participate. Patients were consented to provide a urine and matched venous blood sample. Refusal to provide a blood sample by 107 women was not an exclusion criterion. Urine was collected in sterile containers and tested fresh without processing in the triage area. The result of the CRD Paper Test was read at three minutes. The team used immunoassays to measure levels of urine and serum soluble fms-like tyrosine kinase-1 (sFlt-1) and placental growth factor (PlGF). The sFlt-1/PlGF ratios were calculated and used for comparison with the results of the CRD Paper Test.

The team reported that 89 of the pregnant women had a clinical diagnosis of preeclampsia. Of those, 79% were induced due to preeclampsia, with an average age of delivery at 33 weeks gestation. The team found the CRD test was superior to the other biochemical tests, with an accuracy rate of 86%. Urine congophilia was detected in 14 (12%) patients admitted with an uncertain diagnosis and in only 59 (58%) patients admitted with a diagnosis of PE established or confirmed in triage. There were nine (8%) instances of positive congophilia in the group of patients discharged home absent PE. The CRD Paper Test was positive in just four (36%) patients discharged with a diagnosis of PE.

Kara M. Rood, MD, a maternal-fetal medicine physician and first author of the study, said, “This is the first clinical study using the point-of-care, paper-based Congo Red Dot (CRD) diagnostic test, and the mechanism proved superior in establishing or ruling out a diagnosis of preeclampsia. Our findings will have a huge impact on the health of women and children.” The study was published on March 1, 2019, in the journal EClinicalMedicine.

Related Links:
The Ohio State University College of Medicine
Wexner Medical Center

Gold Member
Chagas Disease Test
CHAGAS Cassette
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Toxoplasma Gondii Immunoassay
Toxo IgM AccuBind ELISA Kit
New
HIV-1 Test
HIV-1 Real Time RT-PCR Kit

Print article

Channels

Molecular Diagnostics

view channel
Image: Researcher Kanta Horie places a sample in a mass spectrometer that measures protein levels in blood plasma and other fluids (Photo courtesy of WashU Medicine)

Highly Accurate Blood Test Diagnoses Alzheimer’s and Measures Dementia Progression

Several blood tests are currently available to assist doctors in diagnosing Alzheimer's disease in individuals experiencing cognitive symptoms. However, these tests do not provide insights into the clinical... Read more

Immunology

view channel
Image: The findings were based on patients from the ADAURA clinical trial of the targeted therapy osimertinib for patients with NSCLC with EGFR-activated mutations (Photo courtesy of YSM Multimedia Team)

Post-Treatment Blood Test Could Inform Future Cancer Therapy Decisions

In the ongoing advancement of personalized medicine, a new study has provided evidence supporting the use of a tool that detects cancer-derived molecules in the blood of lung cancer patients years after... Read more

Microbiology

view channel
Image: Schematic representation illustrating the key findings of the study (Photo courtesy of UNIST)

Breakthrough Diagnostic Technology Identifies Bacterial Infections with Almost 100% Accuracy within Three Hours

Rapid and precise identification of pathogenic microbes in patient samples is essential for the effective treatment of acute infectious diseases, such as sepsis. The fluorescence in situ hybridization... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.